The global Next Generation Sequencing (NGS) Solution market was valued at US$ 3690 million in 2023 and is anticipated to reach US$ 10060 million by 2030, witnessing a CAGR of 15.4% during the forecast period 2024-2030.

Next Generation Sequencing (NGS) Solution Market

Next Generation Sequencing (NGS), also known as high-throughput sequencing, refers to advanced genomic technologies that enable the rapid and cost-effective sequencing of DNA or RNA molecules. NGS solutions have revolutionized the field of genomics and have significant applications in various areas of life sciences, including medical research, diagnostics, personalized medicine, agriculture, and environmental studies.

The global market for Next Generation Sequencing (NGS) solutions has experienced significant growth in recent years, driven by the increasing adoption of NGS technologies in various research and clinical applications. NGS has revolutionized genomics research, personalized medicine, and diagnostics, making it one of the most impactful technologies in the life sciences industry. Continuous innovations in NGS platforms, sequencing chemistries, and bioinformatics tools have improved sequencing accuracy, speed, and data analysis capabilities. The increasing focus on understanding the genetic basis of diseases, population genomics, and agricultural genomics has driven the demand for NGS solutions. The United States and Canada are major contributors to the global NGS market due to their well-established research infrastructure and a large number of NGS-based research projects. European countries, including the United Kingdom, Germany, and France, have seen significant NGS adoption in both research and clinical applications. Countries like China, Japan, and India have witnessed rapid growth in the NGS market, driven by increasing research investments and government initiatives. The global market for NGS solutions is expected to continue its growth trajectory in the coming years. The increasing adoption of NGS in clinical diagnostics, precision medicine, and agriculture is likely to drive further market expansion. Moreover, ongoing advancements in NGS technologies, such as single-cell sequencing and long-read sequencing, will continue to unlock new research possibilities and applications, expanding the reach of NGS into various scientific disciplines.

This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing (NGS) Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing (NGS) Solution.

Report Scope

The Next Generation Sequencing (NGS) Solution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Sequencing (NGS) Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next Generation Sequencing (NGS) Solution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Next Generation Sequencing (NGS) Solution Market Report

Report Metric	Details
Report Name	Next Generation Sequencing (NGS) Solution Market
Accounted market size in 2023	US$ 3690 million
Forecasted market size in 2030	US$ 10060 million
CAGR	15.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Whole Genome Sequencing Whole Exome Sequencing Targeted Sequencing and Resequencing Centrifuges
Segment by Application	Sporadic Cancer Inherited Cancer Companion Diagnostics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eurofins Scientific, Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Myriad Genetics, Foundation Medicine, Oxford Nanopore Technologies, Pacific Biosciences, Paradigm Diagnostics, BGI Group, Caris Life Sciences, Partek, Natera, LabCorp, Macrogen, Genotypic Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Sequencing (NGS) Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Next Generation Sequencing (NGS) Solution Market growing?

Ans: The Next Generation Sequencing (NGS) Solution Market witnessing a CAGR of 15.4% during the forecast period 2024-2030.

What is the Next Generation Sequencing (NGS) Solution Market size in 2030?

Ans: The Next Generation Sequencing (NGS) Solution Market size in 2030 will be US$ 10060 million.

Who are the main players in the Next Generation Sequencing (NGS) Solution Market report?

Ans: The main players in the Next Generation Sequencing (NGS) Solution Market are Eurofins Scientific, Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Myriad Genetics, Foundation Medicine, Oxford Nanopore Technologies, Pacific Biosciences, Paradigm Diagnostics, BGI Group, Caris Life Sciences, Partek, Natera, LabCorp, Macrogen, Genotypic Technology

What are the Application segmentation covered in the Next Generation Sequencing (NGS) Solution Market report?

Ans: The Applications covered in the Next Generation Sequencing (NGS) Solution Market report are Sporadic Cancer, Inherited Cancer, Companion Diagnostics, Others

What are the Type segmentation covered in the Next Generation Sequencing (NGS) Solution Market report?

Ans: The Types covered in the Next Generation Sequencing (NGS) Solution Market report are Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing and Resequencing Centrifuges

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next Generation Sequencing (NGS) Solution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Whole Genome Sequencing

1.2.3 Whole Exome Sequencing

1.2.4 Targeted Sequencing and Resequencing Centrifuges

1.3 Market by Application

1.3.1 Global Next Generation Sequencing (NGS) Solution Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Sporadic Cancer

1.3.3 Inherited Cancer

1.3.4 Companion Diagnostics

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next Generation Sequencing (NGS) Solution Market Perspective (2019-2030)

2.2 Next Generation Sequencing (NGS) Solution Growth Trends by Region

2.2.1 Global Next Generation Sequencing (NGS) Solution Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Next Generation Sequencing (NGS) Solution Historic Market Size by Region (2019-2024)

2.2.3 Next Generation Sequencing (NGS) Solution Forecasted Market Size by Region (2025-2030)

2.3 Next Generation Sequencing (NGS) Solution Market Dynamics

2.3.1 Next Generation Sequencing (NGS) Solution Industry Trends

2.3.2 Next Generation Sequencing (NGS) Solution Market Drivers

2.3.3 Next Generation Sequencing (NGS) Solution Market Challenges

2.3.4 Next Generation Sequencing (NGS) Solution Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next Generation Sequencing (NGS) Solution Players by Revenue

3.1.1 Global Top Next Generation Sequencing (NGS) Solution Players by Revenue (2019-2024)

3.1.2 Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Players (2019-2024)

3.2 Global Next Generation Sequencing (NGS) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Next Generation Sequencing (NGS) Solution Revenue

3.4 Global Next Generation Sequencing (NGS) Solution Market Concentration Ratio

3.4.1 Global Next Generation Sequencing (NGS) Solution Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Solution Revenue in 2023

3.5 Next Generation Sequencing (NGS) Solution Key Players Head office and Area Served

3.6 Key Players Next Generation Sequencing (NGS) Solution Product Solution and Service

3.7 Date of Enter into Next Generation Sequencing (NGS) Solution Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Next Generation Sequencing (NGS) Solution Breakdown Data by Type

4.1 Global Next Generation Sequencing (NGS) Solution Historic Market Size by Type (2019-2024)

4.2 Global Next Generation Sequencing (NGS) Solution Forecasted Market Size by Type (2025-2030)

5 Next Generation Sequencing (NGS) Solution Breakdown Data by Application

5.1 Global Next Generation Sequencing (NGS) Solution Historic Market Size by Application (2019-2024)

5.2 Global Next Generation Sequencing (NGS) Solution Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Next Generation Sequencing (NGS) Solution Market Size (2019-2030)

6.2 North America Next Generation Sequencing (NGS) Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Next Generation Sequencing (NGS) Solution Market Size by Country (2019-2024)

6.4 North America Next Generation Sequencing (NGS) Solution Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next Generation Sequencing (NGS) Solution Market Size (2019-2030)

7.2 Europe Next Generation Sequencing (NGS) Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2019-2024)

7.4 Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size (2019-2030)

8.2 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Region (2019-2024)

8.4 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Next Generation Sequencing (NGS) Solution Market Size (2019-2030)

9.2 Latin America Next Generation Sequencing (NGS) Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Next Generation Sequencing (NGS) Solution Market Size by Country (2019-2024)

9.4 Latin America Next Generation Sequencing (NGS) Solution Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size (2019-2030)

10.2 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Country (2019-2024)

10.4 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eurofins Scientific

11.1.1 Eurofins Scientific Company Detail

11.1.2 Eurofins Scientific Business Overview

11.1.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Introduction

11.1.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.1.5 Eurofins Scientific Recent Development

11.2 Illumina

11.2.1 Illumina Company Detail

11.2.2 Illumina Business Overview

11.2.3 Illumina Next Generation Sequencing (NGS) Solution Introduction

11.2.4 Illumina Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.2.5 Illumina Recent Development

11.3 PerkinElmer

11.3.1 PerkinElmer Company Detail

11.3.2 PerkinElmer Business Overview

11.3.3 PerkinElmer Next Generation Sequencing (NGS) Solution Introduction

11.3.4 PerkinElmer Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.3.5 PerkinElmer Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Detail

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Introduction

11.4.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Roche Holding

11.5.1 Roche Holding Company Detail

11.5.2 Roche Holding Business Overview

11.5.3 Roche Holding Next Generation Sequencing (NGS) Solution Introduction

11.5.4 Roche Holding Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.5.5 Roche Holding Recent Development

11.6 Agilent Technologies

11.6.1 Agilent Technologies Company Detail

11.6.2 Agilent Technologies Business Overview

11.6.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Introduction

11.6.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.6.5 Agilent Technologies Recent Development

11.7 Myriad Genetics

11.7.1 Myriad Genetics Company Detail

11.7.2 Myriad Genetics Business Overview

11.7.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Introduction

11.7.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.7.5 Myriad Genetics Recent Development

11.8 Foundation Medicine

11.8.1 Foundation Medicine Company Detail

11.8.2 Foundation Medicine Business Overview

11.8.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Introduction

11.8.4 Foundation Medicine Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.8.5 Foundation Medicine Recent Development

11.9 Oxford Nanopore Technologies

11.9.1 Oxford Nanopore Technologies Company Detail

11.9.2 Oxford Nanopore Technologies Business Overview

11.9.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Introduction

11.9.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.9.5 Oxford Nanopore Technologies Recent Development

11.10 Pacific Biosciences

11.10.1 Pacific Biosciences Company Detail

11.10.2 Pacific Biosciences Business Overview

11.10.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Introduction

11.10.4 Pacific Biosciences Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.10.5 Pacific Biosciences Recent Development

11.11 Paradigm Diagnostics

11.11.1 Paradigm Diagnostics Company Detail

11.11.2 Paradigm Diagnostics Business Overview

11.11.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Introduction

11.11.4 Paradigm Diagnostics Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.11.5 Paradigm Diagnostics Recent Development

11.12 BGI Group

11.12.1 BGI Group Company Detail

11.12.2 BGI Group Business Overview

11.12.3 BGI Group Next Generation Sequencing (NGS) Solution Introduction

11.12.4 BGI Group Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.12.5 BGI Group Recent Development

11.13 Caris Life Sciences

11.13.1 Caris Life Sciences Company Detail

11.13.2 Caris Life Sciences Business Overview

11.13.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Introduction

11.13.4 Caris Life Sciences Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.13.5 Caris Life Sciences Recent Development

11.14 Partek

11.14.1 Partek Company Detail

11.14.2 Partek Business Overview

11.14.3 Partek Next Generation Sequencing (NGS) Solution Introduction

11.14.4 Partek Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.14.5 Partek Recent Development

11.15 Natera

11.15.1 Natera Company Detail

11.15.2 Natera Business Overview

11.15.3 Natera Next Generation Sequencing (NGS) Solution Introduction

11.15.4 Natera Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.15.5 Natera Recent Development

11.16 LabCorp

11.16.1 LabCorp Company Detail

11.16.2 LabCorp Business Overview

11.16.3 LabCorp Next Generation Sequencing (NGS) Solution Introduction

11.16.4 LabCorp Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.16.5 LabCorp Recent Development

11.17 Macrogen

11.17.1 Macrogen Company Detail

11.17.2 Macrogen Business Overview

11.17.3 Macrogen Next Generation Sequencing (NGS) Solution Introduction

11.17.4 Macrogen Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.17.5 Macrogen Recent Development

11.18 Genotypic Technology

11.18.1 Genotypic Technology Company Detail

11.18.2 Genotypic Technology Business Overview

11.18.3 Genotypic Technology Next Generation Sequencing (NGS) Solution Introduction

11.18.4 Genotypic Technology Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024)

11.18.5 Genotypic Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Illumina Inc

PerkinElmer Inc

Thermo Fisher Scientific

Oxford Nanopore Technologies

List of Tables

Table 1. Global Next Generation Sequencing (NGS) Solution Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Whole Genome Sequencing

Table 3. Key Players of Whole Exome Sequencing

Table 4. Key Players of Targeted Sequencing and Resequencing Centrifuges

Table 5. Global Next Generation Sequencing (NGS) Solution Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Next Generation Sequencing (NGS) Solution Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Next Generation Sequencing (NGS) Solution Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Next Generation Sequencing (NGS) Solution Market Share by Region (2019-2024)

Table 9. Global Next Generation Sequencing (NGS) Solution Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Next Generation Sequencing (NGS) Solution Market Share by Region (2025-2030)

Table 11. Next Generation Sequencing (NGS) Solution Market Trends

Table 12. Next Generation Sequencing (NGS) Solution Market Drivers

Table 13. Next Generation Sequencing (NGS) Solution Market Challenges

Table 14. Next Generation Sequencing (NGS) Solution Market Restraints

Table 15. Global Next Generation Sequencing (NGS) Solution Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Next Generation Sequencing (NGS) Solution Market Share by Players (2019-2024)

Table 17. Global Top Next Generation Sequencing (NGS) Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) Solution as of 2023)

Table 18. Ranking of Global Top Next Generation Sequencing (NGS) Solution Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Next Generation Sequencing (NGS) Solution Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Next Generation Sequencing (NGS) Solution Product Solution and Service

Table 22. Date of Enter into Next Generation Sequencing (NGS) Solution Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Next Generation Sequencing (NGS) Solution Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Type (2019-2024)

Table 26. Global Next Generation Sequencing (NGS) Solution Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Type (2025-2030)

Table 28. Global Next Generation Sequencing (NGS) Solution Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Application (2019-2024)

Table 30. Global Next Generation Sequencing (NGS) Solution Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Application (2025-2030)

Table 32. North America Next Generation Sequencing (NGS) Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Next Generation Sequencing (NGS) Solution Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Next Generation Sequencing (NGS) Solution Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Next Generation Sequencing (NGS) Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Next Generation Sequencing (NGS) Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Next Generation Sequencing (NGS) Solution Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Next Generation Sequencing (NGS) Solution Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Country (2025-2030) & (US$ Million)

Table 47. Eurofins Scientific Company Detail

Table 48. Eurofins Scientific Business Overview

Table 49. Eurofins Scientific Next Generation Sequencing (NGS) Solution Product

Table 50. Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 51. Eurofins Scientific Recent Development

Table 52. Illumina Company Detail

Table 53. Illumina Business Overview

Table 54. Illumina Next Generation Sequencing (NGS) Solution Product

Table 55. Illumina Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 56. Illumina Recent Development

Table 57. PerkinElmer Company Detail

Table 58. PerkinElmer Business Overview

Table 59. PerkinElmer Next Generation Sequencing (NGS) Solution Product

Table 60. PerkinElmer Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 61. PerkinElmer Recent Development

Table 62. Thermo Fisher Scientific Company Detail

Table 63. Thermo Fisher Scientific Business Overview

Table 64. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product

Table 65. Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 66. Thermo Fisher Scientific Recent Development

Table 67. Roche Holding Company Detail

Table 68. Roche Holding Business Overview

Table 69. Roche Holding Next Generation Sequencing (NGS) Solution Product

Table 70. Roche Holding Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 71. Roche Holding Recent Development

Table 72. Agilent Technologies Company Detail

Table 73. Agilent Technologies Business Overview

Table 74. Agilent Technologies Next Generation Sequencing (NGS) Solution Product

Table 75. Agilent Technologies Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 76. Agilent Technologies Recent Development

Table 77. Myriad Genetics Company Detail

Table 78. Myriad Genetics Business Overview

Table 79. Myriad Genetics Next Generation Sequencing (NGS) Solution Product

Table 80. Myriad Genetics Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 81. Myriad Genetics Recent Development

Table 82. Foundation Medicine Company Detail

Table 83. Foundation Medicine Business Overview

Table 84. Foundation Medicine Next Generation Sequencing (NGS) Solution Product

Table 85. Foundation Medicine Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 86. Foundation Medicine Recent Development

Table 87. Oxford Nanopore Technologies Company Detail

Table 88. Oxford Nanopore Technologies Business Overview

Table 89. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product

Table 90. Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 91. Oxford Nanopore Technologies Recent Development

Table 92. Pacific Biosciences Company Detail

Table 93. Pacific Biosciences Business Overview

Table 94. Pacific Biosciences Next Generation Sequencing (NGS) Solution Product

Table 95. Pacific Biosciences Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 96. Pacific Biosciences Recent Development

Table 97. Paradigm Diagnostics Company Detail

Table 98. Paradigm Diagnostics Business Overview

Table 99. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product

Table 100. Paradigm Diagnostics Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 101. Paradigm Diagnostics Recent Development

Table 102. BGI Group Company Detail

Table 103. BGI Group Business Overview

Table 104. BGI Group Next Generation Sequencing (NGS) Solution Product

Table 105. BGI Group Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 106. BGI Group Recent Development

Table 107. Caris Life Sciences Company Detail

Table 108. Caris Life Sciences Business Overview

Table 109. Caris Life Sciences Next Generation Sequencing (NGS) Solution Product

Table 110. Caris Life Sciences Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 111. Caris Life Sciences Recent Development

Table 112. Partek Company Detail

Table 113. Partek Business Overview

Table 114. Partek Next Generation Sequencing (NGS) Solution Product

Table 115. Partek Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 116. Partek Recent Development

Table 117. Natera Company Detail

Table 118. Natera Business Overview

Table 119. Natera Next Generation Sequencing (NGS) Solution Product

Table 120. Natera Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 121. Natera Recent Development

Table 122. LabCorp Company Detail

Table 123. LabCorp Business Overview

Table 124. LabCorp Next Generation Sequencing (NGS) Solution Product

Table 125. LabCorp Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 126. LabCorp Recent Development

Table 127. Macrogen Company Detail

Table 128. Macrogen Business Overview

Table 129. Macrogen Next Generation Sequencing (NGS) Solution Product

Table 130. Macrogen Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 131. Macrogen Recent Development

Table 132. Genotypic Technology Company Detail

Table 133. Genotypic Technology Business Overview

Table 134. Genotypic Technology Next Generation Sequencing (NGS) Solution Product

Table 135. Genotypic Technology Revenue in Next Generation Sequencing (NGS) Solution Business (2019-2024) & (US$ Million)

Table 136. Genotypic Technology Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Next Generation Sequencing (NGS) Solution Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Next Generation Sequencing (NGS) Solution Market Share by Type: 2023 VS 2030

Figure 3. Whole Genome Sequencing Features

Figure 4. Whole Exome Sequencing Features

Figure 5. Targeted Sequencing and Resequencing Centrifuges Features

Figure 6. Global Next Generation Sequencing (NGS) Solution Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Next Generation Sequencing (NGS) Solution Market Share by Application: 2023 VS 2030

Figure 8. Sporadic Cancer Case Studies

Figure 9. Inherited Cancer Case Studies

Figure 10. Companion Diagnostics Case Studies

Figure 11. Others Case Studies

Figure 12. Next Generation Sequencing (NGS) Solution Report Years Considered

Figure 13. Global Next Generation Sequencing (NGS) Solution Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Next Generation Sequencing (NGS) Solution Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Next Generation Sequencing (NGS) Solution Market Share by Region: 2023 VS 2030

Figure 16. Global Next Generation Sequencing (NGS) Solution Market Share by Players in 2023

Figure 17. Global Top Next Generation Sequencing (NGS) Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) Solution as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Next Generation Sequencing (NGS) Solution Revenue in 2023

Figure 19. North America Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Next Generation Sequencing (NGS) Solution Market Share by Country (2019-2030)

Figure 21. United States Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Next Generation Sequencing (NGS) Solution Market Share by Country (2019-2030)

Figure 25. Germany Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Share by Region (2019-2030)

Figure 33. China Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Next Generation Sequencing (NGS) Solution Market Share by Country (2019-2030)

Figure 41. Mexico Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Share by Country (2019-2030)

Figure 45. Turkey Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Next Generation Sequencing (NGS) Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Eurofins Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 48. Illumina Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 49. PerkinElmer Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 51. Roche Holding Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 52. Agilent Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 53. Myriad Genetics Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 54. Foundation Medicine Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 55. Oxford Nanopore Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 56. Pacific Biosciences Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 57. Paradigm Diagnostics Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 58. BGI Group Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 59. Caris Life Sciences Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 60. Partek Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 61. Natera Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 62. LabCorp Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 63. Macrogen Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 64. Genotypic Technology Revenue Growth Rate in Next Generation Sequencing (NGS) Solution Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Genome Engineering Editing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34Q14901

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Nasal Administration Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12L16880

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Ggrade Probiotics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-32O11372

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Rapid Diagnostic Reagent Filler Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38K13957

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions